These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32525247)

  • 1. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
    Gao F; Huang G; Xiao J
    Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chalcone Derivatives: Role in Anticancer Therapy.
    Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
    WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
    Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview.
    Xiao J; Gao M; Diao Q; Gao F
    Curr Top Med Chem; 2021; 21(5):348-362. PubMed ID: 33092509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents.
    Yang J; Lv J; Cheng S; Jing T; Meng T; Huo D; Ma X; Wen R
    Anticancer Agents Med Chem; 2023; 23(11):1265-1283. PubMed ID: 36825723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current scenario of chalcone hybrids with antibreast cancer therapeutic applications.
    Wang H; Zhu J; Zhang Q; Tang J; Huang X
    Arch Pharm (Weinheim); 2024 May; 357(5):e2300640. PubMed ID: 38227398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Activity of Natural and Synthetic Chalcones.
    Constantinescu T; Lungu CN
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
    Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
    Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer.
    Malla RR; Siragam S; Dadi V; Seetini B
    Crit Rev Immunol; 2022; 42(6):27-39. PubMed ID: 37082949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterocyclic chalcone analogues as potential anticancer agents.
    Sharma V; Kumar V; Kumar P
    Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
    Srinivasan B; Johnson TE; Lad R; Xing C
    J Med Chem; 2009 Nov; 52(22):7228-35. PubMed ID: 19883086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
    Xu Z; Zhao SJ; Liu Y
    Eur J Med Chem; 2019 Dec; 183():111700. PubMed ID: 31546197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in chalcones with anticancer activities.
    Karthikeyan C; Moorthy NS; Ramasamy S; Vanam U; Manivannan E; Karunagaran D; Trivedi P
    Recent Pat Anticancer Drug Discov; 2015; 10(1):97-115. PubMed ID: 25138130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).
    Xiao J; Gao M; Sun Z; Diao Q; Wang P; Gao F
    Eur J Med Chem; 2020 Dec; 208():112830. PubMed ID: 32992133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin-derived hybrids and their anticancer activity.
    Gao F; Sun Z; Kong F; Xiao J
    Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the Potential of Chalcone-Sulfonamide Hybrids: A Systematic Review on Their Anticancer Activity and Mechanisms of Action.
    Souza JMT; Silva SANM; Rocha RBD; Machado FDS; Marinho Filho JDB; Araújo AJ
    Cell Biochem Funct; 2024 Sep; 42(7):e70001. PubMed ID: 39425507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review: Discovering 1,3,4-oxadiazole and Chalcone Nucleus for Cytotoxicity / EGFR Inhibitory Anticancer Activity.
    Patil S; Bhandari S
    Mini Rev Med Chem; 2022; 22(5):805-820. PubMed ID: 34477516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective.
    Kumar V; Dhawan S; Girase PS; Awolade P; Shinde SR; Karpoormath R; Singh P
    Curr Med Chem; 2021 Oct; 28(33):6805-6845. PubMed ID: 33749549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
    Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
    Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.